Anavex Life Sciences Corp (AVXL)

[seventhwave]

Among AVXL's institutional holders, one that stands out is a proven "early bird"...Knoll Capital of Medivation fame. Will he be able to repeat history??? The following excerpt is from Forbes...

"...the biggest individual winner of the Medivation saga is a little known New York-based investor named Fred Knoll.

Knoll runs a trust for the benefit of his family and it was the fifth-biggest owner of Medivation’s shares at the end of 2015, behind giants Fidelity, Vanguard, BlackRock and Wells Fargo. Those firms, of course, own the stock on behalf of many clients and none of those firms have bet bigger or longer on Medivation than Knoll. His 2.67% stake in Medivation made up 79% of Knoll’s $270 million U.S. stock portfolio at the end of 2015, Securities & Exchange Commission filings show. Knoll’s stake in Medivation alone is now worth $270 million.

Knoll has been betting on Medivation for many years. He has been a major shareholder of Medivation since it was a penny stock in 2005, when Knoll first disclosed owning 15% of the company. To be prudent, Knoll has sold some of his Medivation shares since then, but the stock just kept rising as Medivation developed Xtandi, a $2 billion prostate cancer drug, in partnership with a Japanese company. Medivation’s stock has returned 9,664% since Knoll first disclosed his ownership in the company..."